Physician

Satya V. Garimella, M.D.

According to 2025 Medicare claims, Satya Garimella, M.D. (NPI: 1164452850) practices cardiac electrophysiology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP INC (NPI: 1780961300; TIN: 205497203) and primary practice location at 47150-4990. Garimella is affiliated with the Baptist Health Care Partners, LLC (ACO ID: A2975), participating under the MSSP model.

Garimella's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 5,307 HCPCS/CPT codes, and received $289,866 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,818 prescription claims across 628 beneficiaries totaling $964,653 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 22 claims. Open Payments data shows 64 records totaling $9,882. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $296,389 to $964,653. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,344	3,856	$241,218
2016	538	3,350	$272,560
2017	544	3,618	$277,881
2018	609	5,163	$332,858
2019	711	4,972	$358,714
2020	620	4,344	$293,303
2021	878	5,257	$355,288
2022	1,078	5,658	$279,479
2023	1,153	5,757	$285,961
2024	1,054	5,307	$289,866

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	299	1,481	$296,389
2016	197	1,189	$136,383
2017	240	1,825	$169,657
2018	299	2,003	$203,380
2019	384	2,522	$295,768
2020	458	3,394	$433,538
2021	513	3,934	$605,096
2022	538	4,012	$783,532
2023	605	4,406	$946,671
2024	628	4,818	$964,653

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	30	$1,026
2021	N/R	N/R	N/R
2022	N/R	22	$396
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	492	836	$88
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	143	147	$50
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	181	564	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	469	787	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	346	426	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	539	27,404	$530,551
Xarelto	Rivaroxaban	168	9,710	$177,052
Multaq	Dronedarone Hcl	40	2,220	$58,149
Entresto	Sacubitril/Valsartan	34	2,670	$55,007
Farxiga	Dapagliflozin Propanediol	30	1,740	$32,636

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$4,132	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$5,750	Elutia, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Satya V. Garimella, M.D.?

Tedicare shows public-source Medicare data for Satya V. Garimella, M.D. (NPI 1164452850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Satya V. Garimella, M.D. have ACO affiliation data?

Satya V. Garimella, M.D. is shown with ACO affiliation data for Baptist Health Care Partners, LLC (MSSP, ACO ID A2975).

What billing organization is linked to Satya V. Garimella, M.D.?

Satya V. Garimella, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP INC (billing NPI 1780961300) in the available physician profile data.

Does Satya V. Garimella, M.D. have Open Payments data?

Satya V. Garimella, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.